ArticleBMC neurology2026
Genotype-phenotype relationship in a cohort of 131 Chinese patients with myotonic dystrophy type 1.
Article in BMC neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
introductionMyotonic dystrophy type 1 (DM1) is an autosomal dominant dynamic mutation disorder characterized by myotonia and muscle weakness. The genotype-phenotype relationship has not been clearly defined in Chinese patients.
methodsThe clinical and genetic characteristics of 131 patients from 105 pedigrees were retrospectively analyzed. Triplet-primed Polymerase Chain Reaction (PCR) and Flanking PCR were performed to analyze the CTG repeats in DMPK gene.
resultsAmong 131 DM1 patients, 64.9% were male, indicating a higher male admission rate, possibly due to limited diagnostic awareness in China. Notably, 11.5% of patients were not initially diagnosed in Neurology Department. The linear negative correlation between CTG repeat number and age of onset was no longer valid when CTG repeats exceeded approximately 400. Forced vital capacity (FVC) was negatively correlated with CTG repeat number, while no significant correlations were found with the Modified Scheltens score, creatine kinase, troponin T, lipid profile, glycosylated hemoglobin, fasting glucose, or BMI. In 16 families studied, CTG repeats expanded in 13 and contracted in 2. White matter lesions were detected in 97.9% of patients, predominantly in the supratentorial region, bilaterally affecting the frontal lobes, temporal poles, and deep white matter.
conclusionOur results provide insightful information on the clinical and genetic characteristics of the largest Chinese cohort of DM1 patients to date and clarify genotype-phenotype relationship.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.